Havrilesky, Laura J <br/><br/>
Economic impact of paclitaxel shortage in patients with newly diagnosed ovarian cancer.  [electronic resource] 

 -  Gynecologic oncology  Jun 2012 
 - 631-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1095-6859 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2012.03.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Phytogenic--economics<br/>Antineoplastic Combined Chemotherapy Protocols--economics<br/>Carboplatin--administration & dosage<br/>Docetaxel<br/>Drug Costs--statistics & numerical data<br/>Female<br/>Humans<br/>Markov Chains<br/>Ovarian Neoplasms--drug therapy<br/>Paclitaxel--administration & dosage<br/>Quality of Life<br/>Taxoids--administration & dosage<br/>United States